Work

Oncology drug expenditure governance in an antineoplastic drug unit: comparative economic analysis 2023–2025 and the stratified recovery rate

Year: 2026
Type: article
Abstract: Introduction: Direct hospital pharmaceutical expenditure in Italy grew by +6.0% in 2025. Antineoplastic Drug Units (ADUs) play a key governance role through AIFA registry management, managed entry agreement (MEA) recovery, and prescribing appropriateness monitoring. No standardized indicator distinguishes recoveries dependent on local activity from those determined nationally. Methods: Retrospective three-year comparative economic analysis, 2023-2025, at the ADU of a local health authority in southern Italy (~540,000 inhabitants). Expenditure, patient volumes, preparation counts, and recoveries were extracted from the AIFA registry platform and ADU management system. Recoveries were stratified into Tier 1 (national: AIFA MEA rebates, Innovative Drug Fund receipts) and Tier 2 (local: Law 648/96 recoveries, trial and compassionate use cost avoidance). Gross (all recoveries over net expenditure) and Local (Tier 2 over net expenditure) Recovery Rates were calculated. Results: Net expenditure grew +8.0% in 2023, +19.0% in 2024 and +3.86% in 2025, below the +6.0% national growth, despite a +19.2% increase in treated patients (3,341 vs 2,804) and +21.8% in preparations. Cost per patient decreased from €11,286 to €9,837 (-12.8%). Total recoveries were €5,261,136, €5,291,062, and €8,918,159. The Gross Recovery Rate was 19.8%, 16.7%, and 27.1%; the Local Recovery Rate was 6.7%, 4.7%, and 6.5%. Conclusions: The ADU governance model was associated with simultaneous expansion of patient access and reduction of per-patient cost. The stratified Recovery Rate separates recoveries dependent on local activity from those determined nationally, offering a transparent, reproducible indicator for benchmarking ADU governance across Italian NHS settings and European health systems with national MEA frameworks.
Language: English
Open Access status: gold
Estimated APC paid: $1,617
OpenAlex ID: W7235390935
FWCI:
Cites: 2
Cited by:
Related to: 10